Laryngeal cancer other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Laryngeal cancer}}
{{Laryngeal cancer}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}} {{OK}}, {{Faizan}}


==Overview==
==Overview==
Line 7: Line 7:


==Other Imaging Findings==
==Other Imaging Findings==
Other imaging findings for [[laryngeal cancer]] inlcude:
Other imaging findings for [[laryngeal cancer]] inlcude:<ref name="pmid21674668">{{cite journal |vauthors=Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC |title=Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial |journal=Head Neck |volume=33 |issue=7 |pages=935–40 |date=July 2011 |pmid=21674668 |doi=10.1002/hed.21566 |url=}}</ref><ref name="pmid18023031">{{cite journal |vauthors=Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J |title=Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study |journal=Head Neck |volume=30 |issue=4 |pages=471–8 |date=April 2008 |pmid=18023031 |doi=10.1002/hed.20734 |url=}}</ref>


Fluoro-D-glucose [[positron emission tomography]] [[PET]] which is taken up more by actively [[metabolic]] cells
Fluoro-D-glucose [[positron emission tomography]] [[PET]] which is taken up more by actively [[metabolic]] cells

Revision as of 22:37, 10 January 2019

Laryngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Laryngeal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal cancer other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal cancer other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal cancer other imaging findings

CDC on Laryngeal cancer other imaging findings

Laryngeal cancer other imaging findings in the news

Blogs on Laryngeal cancer other imaging findings

Directions to Hospitals Treating Laryngeal cancer

Risk calculators and risk factors for Laryngeal cancer other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Faizan Sheraz, M.D. [3]

Overview

Other imaging findings for laryngeal cancer inlcude Fluoro-D-glucose positron emission tomography PET which is taken up more by actively metabolic cells. In case of small glottic tumors further imaging may be unnecessary. Laryngoscopy can be helpful to visualize the tumor.

Other Imaging Findings

Other imaging findings for laryngeal cancer inlcude:[1][2]

Fluoro-D-glucose positron emission tomography PET which is taken up more by actively metabolic cells

Laryngoscopy

In case of small glottic tumors further imaging may be unnecessary. Laryngoscopy can be helpful to visualize the tumor.

References

Template:WikiDoc Sources

  1. Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC (July 2011). "Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial". Head Neck. 33 (7): 935–40. doi:10.1002/hed.21566. PMID 21674668.
  2. Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J (April 2008). "Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study". Head Neck. 30 (4): 471–8. doi:10.1002/hed.20734. PMID 18023031.